MainRegistrationLogin Export Department
Tuesday, 2024-03-19, 10:18 AM
Login form
Site menu

Section categories
Pharmaceuticals photos [96]
Company Photos [0]

Search

Statistics

Total online: 1
Guests: 1
Users: 0

Main » Photo album » Pharmaceuticals photos » Optoflame- Eye Drops
Optoflame
Eye Drops
Anti-inflammatory

Composition :
Each 1ml contains :
Diclofenac sodium 1 mg .

Properties :
Optoflame eye drops contains diclofenac sodium as an active substance
which has a potent anti-inflammatory effect , through inhibition of
prostaglandin synthetase enzyme .

Indications & usage :
- Post-operative inflammation in patients who have undergone cataract
extraction .
- Photophobia in patients undergoing incisional refractive surgery .

Contra-indications :
- Hypersensitivity to diclofenac .
- In pregnancy except if clearly needed .
- Late pregnancy – pediatrics .
- Patients concurrently wearing soft contact lenses .
- Patients wearing hydrogel soft contact lenses who have concurrently
experienced ocular irritation manifested by redness and burning .

Side effects :
- Keratitis , anterior chamber reaction and ocular allergy .
- Mild to moderate transient stinging and or blurred vision may be occur .

Drug interactions :
Concomitant use of Optoflame eye drop with topical steroids may increase the
potential for healing problems .

Warnings and precautions:
Should not be used over contact lenses .
Use with care in patients sensitive to acetyl salicylic acid or non steroidal
anti – inflammatory drugs .

Use with caution in patients who are known to be had bleeding tendency or
who are receiving other medications that may prolong bleeding time .

Dosage and administration:
One drop 3 – 5 times daily according to the patient's condition and the
instruction of the physician .

Packing :
Self dropper plastic bottle of 5 ml .

Storage :
Store at a temperature ( 15-25 ) o C .

Views: 2159 | Dimensions: 800x578px/51.4Kb
Date: 2010-04-14 | Tags: Optoflame- Eye Drops | Added by: Modajaa
View photo in real size
Rating: 0.0/0



  Copyright
 Mohamed Ali Soliman © 2024